Topic resource collection
Approved comparison material connected to this topic.
56 resourcesRead both sides
BPC-157 VEGF upregulation, collagen synthesis, tight junction protein expression (occludin, claudin) 500–1000 mcg daily (split into 2 doses) 4–6 hours Subcutaneous (lower abdomen preferred) Gold standard for structural gut repair…
Cerebrolysin BDNF upregulation, synaptic plasticity enhancement Inattentive-type: working memory deficits, sustained attention 2–3 times per week, 5–10 mL per dose Most evidence-backed for cognitive enhancement; requires IM injec…
Before starting any peptide regimen, understand that different compounds require different administration strategies based on half-life, receptor dynamics, and stacking compatibility. CJC-1295 (no DAC) GH-releasing hormone analog…
BPC-157 Angiogenesis via VEGF upregulation + fibroblast migration Proliferative (days 3–10) 200–500mcg per application Subcutaneous injection near wound site 2–8°C for 28 days (bacteriostatic water) TB-500 (Thymosin Beta-4) Actin…
The table below compares intranasal vs subcutaneous anxiolytic peptide protocols based on administration complexity, onset time, and dosing precision requirements. Selank Intranasal 300–900 mcg/day 15–30 minutes No (pre-mixed) Fa…
Neuroinflammatory brain fog worsens after infections, correlates with inflammatory flares, and often improves temporarily with anti-inflammatory interventions (curcumin, omega-3s, low-histamine diets). Mitochondrial brain fog wor…
Before starting any peptide protocol, understand the trade-offs between compounds, administration routes, and dosing schedules. KPV NF-κB inhibition, cytokine suppression (TNF-α, IL-6) IBS-D, IBS-M 500 mcg/day Once daily (morning…
Cerebrolysin Neurotrophic support (NGF/BDNF mimetic) 5–10 mL daily IM/SC 10–20 days on, 2–4 weeks off Neurotrophic deficiency, age-related decline Gold standard for neurotrophic restoration. Robust clinical data, expensive Dihexa…
| Peptide Class | Primary Mechanism | Standard Dose | Injection Frequency | Cycle Length | Key Co-Factors | Bottom Line ||—|—|—|—|—|—|| TB-500 | Angiogenesis (VEGF upregulation, capillary formation) | 2.5–5mg | 2× weekly loading,…
The table below compares three validated peptide categories used in metabolic research protocols. Each operates through distinct mechanisms and timelines. Growth Hormone Secretagogues (MK 677, CJC-1295) Bind to ghrelin receptors …
Before selecting a peptide protocol, understanding the mechanistic differences between the primary candidates clarifies which approach aligns with the specific pathology. BPC-157 VEGF upregulation, IL-6 suppression, collagen synt…
BPC-157 (Body Protection Compound) Stimulates VEGF and fibroblast proliferation; accelerates collagen type I deposition in tendons 250–500mcg daily, 4–6 weeks Subcutaneous, upper deltoid or arm within 5–8cm of injury Most evidenc…
Systemic Autoimmunity (Lupus, RA, MS) Thymalin Thymic regeneration and Treg expansion via thymulin secretion 5–10mg subcutaneous twice weekly 8–12 weeks for measurable Treg increase, 16–24 weeks for symptom reduction Best for mul…
Thymosin Alpha-1 Upregulates T-regulatory cells, modulates Th1/Th2 balance TGF-beta1, autoimmune signaling 0.75–2mg per injection Subcutaneous 2–3x weekly for 8–12 weeks Best first-line peptide for immune dysregulation; measurabl…
GHRH Monotherapy CJC-1295 (no DAC) + Ipamorelin 1–2x daily (pre-bed, pre-workout) 2–4× baseline during pulses Minimal High. Preserves insulin sensitivity, supports fat loss phases Ghrelin Agonist Monotherapy MK-677 (ibutamoren) O…
BPC-157 VEGF upregulation, angiogenesis 250–500mcg Twice daily Tendons, ligaments, gastric tissue 2–8°C, 28 days max Gold standard for localized soft tissue repair. Fastest results in tendon injuries TB-500 Actin regulation, cell…